Compliance with Yaz Flex supported by the CADDY

• Research type

  Research Study

• Full title

  A multicenter, open-label, randomized, controlled, two-arm study to assess compliance with daily tablet intake of women on treatment with the oral contraceptive SH T00186D/BAY 86-5300 (0.02 mg ethinyl estradiol as betadex clathrate and 3 mg drospirenone) in a flexible extended regimen supported by a dispenser (CADDY) with a reminder function over 12 months

• IRAS ID

  56695

• Contact name

  Nell Wyatt

• Sponsor organisation

  Bayer HealthCare AG, c/o Bayer plc

• Eudract number

  2010-019902-17

• ISRCTN Number

  N/A

• Research summary

  The objective of the study is to evaluate the effect of the dispenseris buzzer function on compliance with daily tablet intake of an ethinyl estradiol (EE) drispirenone (DRSP) containing oral contraceptive (OC) in a flexible extended regimen when administered for approximately 12 months to healthy female volunteers who request contraception.

• REC name

  South Central - Oxford B Research Ethics Committee

• REC reference

  10/H0605/68

• Date of REC Opinion

  17 Dec 2010

• REC opinion

  Further Information Favourable Opinion